Kolexia
Chauveau Aurélie
Pharmacien
Centre hospitalier de Cornouaille
Quimper, France
57 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Polyglobulie Thrombocytose Thrombocytémie essentielle Polyglobulie primitive essentielle Syndromes myéloprolifératifs Myélofibrose primitive Thrombose Leucémie aigüe myéloïde Prédisposition génétique à une maladie

Industries

Novartis
2 collaboration(s)
Dernière en 2023
WERFEN
1 collaboration(s)
Dernière en 2022
Janssen
1 collaboration(s)
Dernière en 2022
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.
Blood cancer journal   08 avril 2022
Prevalence and identification of the determinants of influenza vaccination among French midwifery students.
Midwifery   17 juillet 2021
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.
Blood advances   31 mai 2021
Evaluation of beta-2 microglobulin, erythropoietin and tobacco use in polycythemic cases.
International journal of hematology   22 mai 2021
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation.
Blood advances   14 mai 2021
Low incidence of mutations in idiopathic erythrocytosis.
Haematologica   01 janvier 2021
Splicing Anomalies in Myeloproliferative Neoplasms: Paving the Way for New Therapeutic Venues.
Cancers   07 août 2020
'MPN Genomic Calculator': real-life use in a young population with essential thrombocythaemia.
British journal of haematology   30 juin 2020
A novel thrombopoietin (THPO) mutation altering mRNA splicing in a case of familial thrombocytosis.
British journal of haematology   19 mai 2020
Accreditation strategy for rare somatic molecular abnormalities detected or quantified by polymerase chain reaction: GBMHM recommendations.
Annales de biologie clinique   11 mai 2020